Home › Funds › Patient Capital Management, LLC › QXO
Patient Capital Management, LLC position in QXO
QXO INC · Consumer Discretionary
Patient Capital Management, LLC reported holding 10,932,468 shares of QXO (QXO INC) in its Q3 2026 13F filing — a position valued at US$127.8M, representing 4.32% of its reported portfolio and ranking #8 among its reported holdings. Patient Capital Management, LLC has disclosed QXO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's QXO position evolved
Patient Capital Management, LLC first disclosed a stake in QXO in Q3 2024 at 7,741,847 shares (US$122.1M). The position peaked in Q2 2025 at 6,542,202 shares, worth US$140.9M. Across 9 filings, Patient Capital Management, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 10,932,468 shares valued at US$127.8M — an increase of 3,795,799 shares quarter over quarter.. Notable position changes include a 53% increase in Q3 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 7.74M | $122.09M | New |
| Q4 2024 | 7.73M | $122.96M | Hold |
| Q1 2025 | 7.28M | $98.64M | Reduce |
| Q2 2025 | 6.54M | $140.92M | Reduce |
| Q3 2025 | 6.54M | $124.60M | Hold |
| Q4 2025 | 6.47M | $124.78M | Reduce |
| Q1 2026 | 6.78M | $131.64M | Add |
| Q2 2026 | 7.14M | $123.32M | Add |
| Q3 2026 | 10.93M | $127.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QXO and 13F data
QXO (QXO INC) is a Consumer Discretionary company. 48 other funds we track also report a position in QXO — the largest reported positions include Orbis Allan Gray Ltd (US$1.28B), Baillie Gifford & Co (US$544.0M), FRED ALGER MANAGEMENT, LLC (US$472.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QXO
- Orbis Allan Gray Ltd 73.95M sh · $1.28B · Q2 2026
- Baillie Gifford & Co 46.53M sh · $543.96M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 27.36M sh · $472.82M · Q2 2026
- Alpha Wave Global, LP 24.39M sh · $421.46M · Q2 2026
- HRTG GPE, LLC 27.10M sh · $316.83M · Q3 2026
- MFN Partners Management, LP 23.45M sh · $274.18M · Q3 2026
- Finepoint Capital LP 23.36M sh · $273.03M · Q3 2026
- Maniro Ltd 12.05M sh · $208.18M · Q2 2026
- Consulta Ltd 12.00M sh · $207.36M · Q2 2026
- Blue Investment Opportunities, LLC - Project Breeze Series 1 8.07M sh · $139.50M · Q2 2026
- MTCO Ltd. 10.94M sh · $127.90M · Q3 2026
- SOFTBANK GROUP CORP. 5.47M sh · $94.53M · Q2 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held QXO?
Patient Capital Management, LLC has disclosed QXO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Patient Capital Management, LLC's current position in QXO?
As of Q3 2026, Patient Capital Management, LLC holds 10.93M shares of QXO (QXO INC), valued at $127.80M, representing 4.32% of its reported portfolio and ranking #8.
Has Patient Capital Management, LLC been buying or selling QXO?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC increased its position in QXO. The position peaked in Q2 2025 at 6.54M shares.
Which other funds hold QXO?
Other major institutional holders of QXO include Orbis Allan Gray Ltd, Baillie Gifford & Co, FRED ALGER MANAGEMENT, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.